Case Report
Copyright ©2013 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastrointest Oncol. Aug 15, 2013; 5(8): 177-180
Published online Aug 15, 2013. doi: 10.4251/wjgo.v5.i8.177
Neuroendocrine tumor metastatic to the orbit treated with radiotherapy
Renata D’Alpino Peixoto, Howard John Lim, Winson Y Cheung
Renata D’Alpino Peixoto, Howard John Lim, Winson Y Cheung, Department of Medical Oncology, BC Cancer Agency, Vancouver, BC V5Z 4E6, Canada
Author contributions: Peixoto RD, Lim HJ and Cheung WY designed the report; Lim HJ and Cheung WY were attending doctors for the patients; Peixoto RD, Lim HJ and Cheung WY organized the report; Peixoto RD, Lim HJ and Cheung WY wrote the paper.
Correspondence to: Renata D’Alpino Peixoto, MD, Department of Medical Oncology, BC Cancer Agency, 600 West 10th, Avenue, Vancouver, BC V5Z 4E6, Canada. renatadalpino@gmail.com
Telephone: +1-604-8776000 Fax: +1-604-8770585
Received: May 25, 2013
Revised: August 12, 2013
Accepted: August 13, 2013
Published online: August 15, 2013
Processing time: 103 Days and 4.6 Hours
Core Tip

Core tip: Neuroendocrine tumors are rare neoplasms that only uncommonly metastasize to the orbit. Given these tumors are associated with prolonged survival despite dissemination, maintaining quality of life by providing early diagnosis and effective treatment to preserve vision and comfort is a fundamental issue. We report the case of a patient who 2 years after the diagnosis of metastaic neuroendocrine tumor to the liver presented with right-sided diplopia. She was found to have metastatic neuroendocrine tumor to the right orbit and was successfully treated with radiotherapy. Eighteen months later, she remains well and with no visual loss.